Groupe Hospitalier de Bretagne Sud
7
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Study of the Characteristics of Chronic Pain in Patients With Addiction
Role: lead
Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner for Patients with Prostate Cancer
Role: lead
Impact of the Therapeutic Education Program "living with a Chronic Inflammatory Disease Under Biotherapy" on Patient Compliance and Quality of Life
Role: lead
VR-MARS Virtual Reality, Medical Assistance and Rescue for Space
Role: lead
Impact of a Task Delegation to ICU Nurses for Midlines' Placement
Role: lead
S-ICD French Cohort Study (HONEST)
Role: collaborator
Evaluation of Two Positions for Free Floating Tracheal Intubation in Weightlessness
Role: lead
All 7 trials loaded